In a statement released on the 1st of May 2018, Unitaid launched a call for proposals to fund innovative projects against TB and drug-resistance. With advances in TB care threatened by drug resistant TB, Unitaid is striving to improve cure rates for people diagnosed with MDR-TB with wider use of best drugs, diagnostics and medication adherence technologies. Wisepill’s evriMED dispensers have been successfully deployed to 1000’s of TB patients worldwide. evriMED is one of a number of innovative tools that can be used to fight TB and for national scale up in countries most affected. The deadline for proposals is Friday, 29 June 2018, 12 Noon CET. For more information on the Unitaid call for proposals, click here.